1Dowell J,Minna JD,Kirkpatrick P.Erlotinib hydrochloride[].Nature Reviews Drug Discovery.2005
2Silvestri GA,,Rivera MP.Targeted therapy for the treatment of ad-vanced non-small cell lung cancer:a review of the epidermal growth factor receptor antagonists[].Chest.2005
3Siegel-Lakhai WS,Beijnen JH,Schellens JH.Current knowledge and future directions of the selective epidermal growth factor re-ceptor inhibitors erlotinib(tarceva)and gefitinib(iressa)[].Onco-logist.2005
4Hidalgo M,Siu L,Nemunaitis J,et al.Phase I and pharmacologic study of OSI-774,an epidermal growth factor receptor tyrosine ki-nase inhibitor,in patients with advanced solid malignancies[].Journal of Clinical Oncology.2001
5Gatzemeier U,Pluzanska A,Szczesna A,et al.Phase III study of erlotinib in combination with cisplatin and gemcitabine in ad-vanced non-small-cell lung cancer:the tarceva lung cancer inves-tigation trial[].Journal of Clinical Oncology.2007
